Amgen stock: buy or sell

AMGN stock price: $240.24 0.65% At close on Jun 21st, 2021

Updated on:
Jun 22nd, 2021


Amgen stock brief

  • Amgen closed on Monday at $240.24 after scarcely changing a 0.65%.
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Should I buy Amgen stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $AMGN stock a buy?

In the current situation of Amgen there is not any eligible buy setup. This doesn't mean we expect a selloff for $AMGN in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Amgen stock?

Knowing when to sell a stock is even harder than knowing when to buy it. As when we have to buy shares, choosing when is appropiate to sell is not a capricious decision, and we must use our own trading style. We like very simple setups to guide us on when is the best time to sell a stock. Be aware that these setups are not intended for selling short $AMGN stock

As a rule of thumb, you must never keep an open trade that leads to higher than expected losses upon purchase. When to sell your stock should always be dictated by the stop-loss (automatic or manual)

Is it time to sell Amgen stock?

In the current situation of Amgen there is not any eligible sell setup, so Amgen stock holders with operations in profit can keep their positions

Amgen ratings

In the last month, 3 analyst ratings were published for Amgen. General sentiment is bullish, with 2 out of 3 publishing optimistic forecasts

Amgen analysts' ratings - Last month
Brokerage firmRating
May 31st, 2021
BMO Capital Markets BuyBuy
Jun 7th, 2021
Oppenheimer Buy
SVB Leerink

Amgen stock analysis

SMAs overview

AMGN stock SMAs chart

Supports and resistances

The current resistances are:

  • R1: $240.69 (0.19% above)
  • R2: $253.09 (5.35% above)
  • R3: $254.61 (5.98% above)
  • The current supports are:

  • S1: $237.68 (-1.07% below)
  • S2: $237.46 (-1.16% below)
  • S3: $236.62 (-1.51% below)
  • Bollinger bands

    The price is moving very close to the upper Bollinger band, indicating some level of overbought in recent sessions. This is not a bearish indicator, as price can trade in these levels for many days and weeks

    AMGN stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 last April after just crossing to the overbough zone for 1 day (weak signal). The RSI value on Monday was 47.43. Since RSI lost the overbought zone, Amgen shares sank a 6.51%

    AMGN stock RSI chart

    Amgen stock price history

    Amgen started trading priced at an adjusted price1 of $0.00 on Jun 1983. Since then, AMGN stock has risen by -, with an average of 0.00% per year. If you had invested $1,000USD in Amgen stock on Jun 1983, it would be valued $inf today.

    1: Adjusted price after possible price splits or reverse-splits

    AMGN stock price history chart

    Price target for Amgen stock

    How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations issue their analysis predicting how a stock will performance in the future.

    Along with buy or sell recommendations, financial institutions post their price estimates based on the stock price action and the company fundamental data. Most of these estimates follow the publication of new financial information by the company, and usually. If you are a small investor you should not buy or sell based on these predictions.

    Averaging all price targets exposed below, the predicted price for Amgen stock is $272.00. Amgen closed at $240.24 on Monday, so the target price is expecting an increase by 13.22%.

    Amgen stock price predictions
    Brokerage firmPrice target
    May 31st, 2021
    BMO Capital Markets $296.00$301.00
    Jun 7th, 2021
    Oppenheimer $272.00$277.00
    SVB Leerink $230.00$238.00

    Earnings and financials

    Last April, Amgen Inc. ($AMGN) reported EPS for that slightly missed Wall St. expectations. Quarterly EPS was $3.70 per share instead of $4.05. This Q1 report represents an earnings surprise of -8.64%. Turnover was $5.9 billion versus $6.3 billion forecasted by analysts.

    In comparison, the EPS for the same quarter last year was $4.17, so reported EPS is a loss of -11.27%. Turnover just changed on an annualized basis in the , from $61.6B to $59.0B last quarter.

    Amgen ($AMGN) is posting financial report late next July. Wall Street expects of $4.05, compared to Q1 that was $3.70.

    Amgen performance

    AMGN performance compared
    Amgen ($AMGN) -5.30% -3.20% 5.00%

    The viewpoints given in this post are personal and should not be followed as recommendations for you to buy or sell stocks. The author of this article does not have any knowledge of the specific circumstances of the reader, his or her own finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are expressed for educative motives only

    Amgen summary

    Monday, June 21st, 2021
    Day range$237.65 - $240.91
    Previous close$238.68
    Session gain0.65%
    Average true range$4.92
    50d mov avg$245.52
    100d mov avg$240.88
    200d mov avg$236.13
    Earnings dateJuly 27th, 2021

    Frequently asked questions

    What is Amgen stock symbol?

    Amgen Inc. is a public company trading in the US stock market with the AMGN symbol

    Is Amgen stock a buy or sell?

    Amgen received 3 ratings in the last 30 days: 2 bullish, 0 bearish and 0 neutral.

    Will AMGN go up?

    Amgen had different price predictions published by market analysts in the last 4 weeks forecasting the target price to $272.00. That is a 13.22% than the last price ($240.24).